跳至主要内容
临床试验/NCT05140070
NCT05140070Unknown不适用

Development and Implementation of an Innovative Technology for the Production New Generation Fruit and Vegetable Products Enriched With Dietary Fibre Preparation From Potato Starch With Prebiotic Properties for Children and Youth

Children's Memorial Health Institute, Poland2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年10月6日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
2
主要终点
BMI z-score change

研究概览

简要总结

The main goal of the project is to test fruit and vegetable mousse, with the addition of a fiber preparation made of potato starch with prebiotic properties, on selected clinical, metabolic and immunological parameters in overweight and obese children.

The study will be performed in a group of 80 to 100 children aged 6 to 10 years (pre-pubertal age), using a double-blind procedure. Children will be randomly assigned into two groups, i.e. the intervention group (they will receive a vegetable and fruit mousse with the addition of potato starch fiber preparation with prebiotic properties) and the control group (they will receive an identical preparation in their diet, but without the addition of potato starch fiber preparation).

详细描述

Purpose and nature of the study:

The study financed by the National Center for Research and Development is aimed at examining the vegetable and fruit mousse with the addition of a potato starch fiber preparation with prebiotic properties, in terms of preventing overweight and obesity in children and limiting the occurrence of metabolic disorders secondary to obesity.

Description of the procedures Children participating in the study will consume a daily fruit and vegetable mousse with or without the addition (control group) of a fiber-based potato starch preparation with prebiotic properties. Random selection will decide whether child will consume vegetable and fruit mousse with the addition of a fiber-based potato starch preparation with prebiotic properties. The study will be double blinded: neither parent and child, nor the attending physician will know whether the consumed mousse contains a fiber preparation. This method of conducting the study (random selection to the study group and control group and the so-called study blind) aims to eliminate the attitude of both the study participant and the observer to the therapy, which could affect the final assessment.

Children will take the mousse every day for six months (6 months). In order to evaluate the effect of fruit and vegetable mousse with the addition of a fiber preparation made of potato starch with prebiotic properties, the following tests will be performed: measurements of height, weight and, based on this measurements body mass index (BMI) will be calculated, waist circumference and blood pressure, bioimpedance test to assess the content of adipose and muscle tissue in the body, ultrasound of the carotid vessels and the liver, the speed of the pulse wave using the oscillometric method, the elastographic examination with a fibroscan, the examination of the composition of the intestinal flora in a stool sample, and a venous blood sample (7-10 ml volume) will be taken to evaluate lipid, carbohydrate metabolism, liver function, adipose tissue function, antioxidant status, and immune response parameters. The mentioned tests will be performed three times during the observation, i.e. at the time of enrollment in the study, after 6 months of taking the fruit and vegetable mousse and 3 months after the end of the vegetable and fruit mousse. In connection with participation in the study, the Child and Parents will be provided with dietary and physical activity advice as well as psychologist's advice on the day of enrollment in the study and at 3-month intervals up to 9 months from the start of participation in the study. Additionally, 3 months after starting taking the fruit and vegetable mousse, anthropometric and blood pressure measurements will be performed. During the participation in the study possible side effects will be registered.

A questionnaire containing questions about the child's date of birth, questions about the child's general health and taking medications, about the socio-demographic situation of the family, and food frequency questions will be completed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

the same appearance of the mousse (with and without active substance)

入排标准

年龄范围
6 Years 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • overweight or obesity according to World Health Organization (WHO) definition
  • in 20 patients additionally to overweight or obesity also increase blood pressure
  • in 20 patients additionally to overweight or obesity also liver steatosis
  • willingness to participate

排除标准

  • allergy to mousse components
  • malabsorption syndrome
  • organ failure
  • food neophobia
  • other diseases or health problems which may interfere with study procedures or safety.

结局指标

主要结局

BMI z-score change

时间窗: 6 to 9 months

Change in age and sex standardized BMI z-scores

次要结局

  • Gut microbiota(6 to 9 months)
  • Cholesterol(6 to 9 months)
  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)(6 to 9 months)
  • total antioxidant status (TAS)(6 to 9 months)
  • Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted (RANTES)(6 months)
  • lymphocyte T(6 months)
  • Waist(6 to 9 months)
  • high-density lipoprotein (HDL)(6 to 9 months)
  • insulin, serum(6 to 9 months)
  • Monocyte Chemoattractant Protein-1 (MCP-1)(6 months)
  • Bioimpedance(6 to 9 months)
  • Triglyceride(6 to 9 months)
  • Low-density lipoprotein (LDL)(6 to 9 months)
  • tumor necrosis factor α (TNF-alfa)(6 months)
  • interleukin 6 (IL-6)(6 months)
  • very low-density lipoprotein (VLDL)(6 to 9 months)
  • apolipoprotein(6 to 9 months)
  • uric acid(6 to 9 months)
  • leptin(6 to 9 months)
  • adiponectin(6 to 9 months)
  • glucose, serum(6 to 9 months)
  • Glutathione (GSH)(6 to 9 months)
  • glutathione peroxidase (GPx)(6 to 9 months)
  • Macrophage Inflammatory Protein-1 (MIP-1) alfa and beta(6 months)

研究者

发起方
Children's Memorial Health Institute, Poland
申办方类型
Other
责任方
Principal Investigator
主要研究者

Piotr Socha

professor

Children's Memorial Health Institute, Poland

研究点 (2)

Loading locations...

相似试验